skip to main content


CMS Issues Physician Payments Sunshine Act Final Rule

Reporting Requirements for Manufacturers of Drugs, Devices, Biologicals and Medical Supplies and Group Purchasing Organizations

February 28, 2013

Download: Printable PDF

The Centers for Medicare and Medicaid Services recently issued final regulations to implement the reporting and transparency requirements set forth in the Patient Protection and Affordable Care Act, also known as the Physician Payments Sunshine Act.  The final regulations require certain manufacturers of drugs, devices, biologicals or medical supplies to report to CMS certain payments or transfers of value to physicians and teaching hospitals.  The Final Rule also requires such manufacturers and certain group purchasing organizations to report certain ownership and investment interests.  We have prepared this alert to provide an overview of the requirements imposed by the Final Rule.

>> Read More


Industries & Featured Services

© Shipman & Goodwin LLP 2020. All Rights Reserved.